NIMA LABS, INC.

SAN FRANCISCO, CA · Founded 2013 · Medtech · Acquired

All-in-one handheld device that grinds food, extracts allergen proteins using proprietary chemistry, performs immunoassay, and interprets results for food allergen detection

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · nima.co

Sector: Medtech
Headquarters: SAN FRANCISCO, CA
Founded: 2013
Latest Form D: $9.3M, May 2016
Total capital: $17M

Federal grants: $3.6M; 5 awards · 2015–2018; Rank in peer group#264 of 538
Private capital raised: $13.5M; 3 Form D · last May 2016; 125 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 5; 3 pending · first 2019; Rank in peer group#111 of 538

Capital timeline

Latest events

Jun 2018Federal grantHealth and Human S · Phase II · An Integrated, Accurate, and Rapid Peanut Allergen Detector for Consumers$1M
Jun 2017Federal grantHealth and Human S · Phase II · An Integrated, Accurate, and Rapid Peanut Allergen Detector for Consumers$1.0M
Aug 2016Federal grantHealth and Human S · Phase II · An Integrated, Accurate, Rapid, and Inexpensive Handheld Consumer Gluten Detector$1.1M
May 2016Private capital raisedForm D · SEC · 3rd filing$9.3M
Feb 2016Federal grantHealth and Human S · Phase I · An Integrated, Accurate, and Rapid Peanut Allergen Detector for Consumers$292K
Sep 2015Federal grantHealth and Human S · Phase II · An Integrated, Accurate, Rapid, and Inexpensive Handheld Consumer Gluten Detector$213K
Sep 2014Private capital raisedForm D · SEC · 2nd filing$4M
Oct 2013Private capital raisedForm D · SEC · 1st filing$200K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

Federal grants#264 · top 49%
Granted patents#111 · top 21%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Scott SundvorResearcherExecutive Officer, DirectorLinked by 5 patents
Brad FeldDirectorNamed in SEC Form D filings
Shireen YatesExecutive Officer, DirectorNamed in SEC Form D filings
Yves SisteronDirectorNamed in SEC Form D filings

What it has protected

USPTO · 5 granted of 8

Nov 17, 2020GrantedSystem And Method For Detection Of Target SubstancesUSPTOUS 10,837,959
Jan 14, 2020GrantedSystem And Method For Detection Of Target SubstancesUSPTOUS 10,533,995
Nov 5, 2019GrantedSystem And Method For Detecting Target SubstancesUSPTOUS 10,466,236

Show all 8 patent records

System And Method For Detection Of Target SubstancesNov 17, 2020 · US 10,837,959Granted
System And Method For Detection Of Target SubstancesJan 14, 2020 · US 10,533,995Granted
System And Method For Detecting Target SubstancesNov 5, 2019 · US 10,466,236Granted
System And Method For Detection Of Target SubstancesApr 9, 2019 · US 10,254,279Granted
System And Method For Detecting Target SubstancesApr 2, 2019 · US 10,249,035Granted
Portable Device For Detection Of Harmful SubstancesJul 5, 2018 · Application 15910692Pending
Anti-gliadin AntibodiesApplication 62408301Pending
Anti-gliadin AntibodiesApplication PCTUS2017056409Pending

BREVITEST TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
PHOTOPHARMICS, INC.Similar federal contract value in Medtech · null in contracts
PIONEAR TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
DIGOSTICS LtdSimilar federal contract value in Medtech · null in contracts
UV Concepts Inc.Similar federal contract value in Medtech · null in contracts
LAZARUS 3D, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.